Clinomics Competitors and Similar CompaniesClear all
Clinomics's competitors and similar companies include Prometheus Biosciences and MorphoSys.
 Clinomics Clinomics (주식회사 클리노믹스) is a biotechnology company that provides genome-based cancer and disease diagnostic solutions. |  Prometheus Biosciences Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases. |  MorphoSys MorphoSys is a biotechnology company focused on the research and development of fully human antibodies. | |
Founding Date | Founding Date 2011 | Founding Date 1995 | Founding Date 1992 |
Type | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations HQ | Locations San Diego, US HQ | Locations Planegg, DE HQ Boston, US |
Employees | Employees N/A | Employees 9735% increase | Employees 464 |
Financial | |||
Revenue (est.) | Revenue (est.) ₩8.5b (FY, 2024) | Revenue (est.) $6.8m (FY, 2022) | Revenue (est.) €238.3m (FY, 2023) |
Cost of goods | Cost of goods ₩7.7b (FY, 2024) | Cost of goods N/A | Cost of goods €34.6m (FY, 2023) |
Gross profit | Gross profit ₩2b (FY, 2024) | Gross profit N/A | Gross profit €205.5m (FY, 2023) |
Net income | Net income (₩47.1b) (FY, 2024) | Net income ($141.8m) (FY, 2022) | Net income (€189.7m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 130m | Total funding raised $ 126m |
For sources of this data, please see the company profile
View Company Profiles
Prometheus Biosciences
HQ
San Diego, US
Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases.
View companyMorphoSys
HQ
Planegg, DE
MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.
View company